Recent advances in idiopathic pulmonary fibrosis

Sanghoon Park, Eun Joo Lee

    Research output: Contribution to journalReview articlepeer-review

    14 Citations (Scopus)


    The concept on idiopathic pulmonary fibrosis (IPF) pathogenesis has progressed from chronic inflammation to aberrant wounding healing and even more to the current paradigms of a multifactorial and heterogeneous disease process. Despite the growth of clinical trials for IPF, most of the results, including N-acetylcysteine combination, warfarin, and bosentan, were disappointing. On the other hand, there have been a number of important developments; the foremost is the licensing of pirfenidone in Europe and Asia. In this article, we briefly review the recent knowledge of pathogenesis of IPF. We also summarize the recent clinical trials regarding the management of IPF. Copyright

    Original languageEnglish
    Pages (from-to)1-6
    Number of pages6
    JournalTuberculosis and Respiratory Diseases
    Issue number1
    Publication statusPublished - 2013 Jan


    • Clinical trial
    • Etiology
    • Idiopathic pulmonary fibrosis

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine
    • Infectious Diseases


    Dive into the research topics of 'Recent advances in idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

    Cite this